Annals of Surgical Oncology Cite Track
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hunt, J. A.
Right arrow Articles by Harman, C. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hunt, J. A.
Right arrow Articles by Harman, C. R.

Annals of Surgical Oncology, Vol 5, Issue 3 248-252, Copyright © 1998 by Society of Surgical Oncology

ARTICLES

Epitrochlear lymph nodes as a site of melanoma metastasis

J. A. Hunt, J. F. Thompson, R. F. Uren, R. Howman-Giles and C. R. Harman
Sydney Melanoma Unit, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia.

BACKGROUND: The incidence of epitrochlear lymph node metastasis for patients with melanomas on the hand or forearm is disputed, and management guidelines for these nodes are unclear. METHODS: The records of 13,139 consecutive melanoma patients were reviewed to document the incidence of metastatic disease in epitrochlear nodes. The frequency of direct lymphatic drainage to epitrochlear nodes was determined for 109 patients with melanomas of the distal upper limb who had undergone preoperative lymphoscintigraphy. RESULTS: Nine of 801 patients (1.1%) with upper limb primary melanomas developed metastatic disease in an epitrochlear node, and one other patient with an occult primary tumor did so. Six of these ten patients underwent elective axillary node dissection at the time of surgery for epitrochlear node disease, and three were found to have metastatic disease in an axillary node. Epitrochlear node metastasis occurred in only two of 83 (2.4%) patients with upper extremity melanoma who underwent therapeutic axillary dissection. Of the 109 patients who underwent lymphoscintigraphy, four (3.7%) demonstrated lymphatic drainage to an epitrochlear node. CONCLUSIONS: Epitrochlear nodal involvement from melanoma of the distal upper extremity is rare, and routine epitrochlear node clearance at the time of either elective or therapeutic axillary dissection for upper extremity melanoma is not indicated. However, it is desirable to perform an axillary dissection whenever surgery for metastatic disease in an epitrochlear node is performed.


This article has been cited by other articles:


Home page
 Arch SurgHome page
A. C. Federico, A. B. Chagpar, M. I. Ross, R. C. G. Martin, R. D. Noyes, J. S. Goydos, P. D. Beitsch, M. M. Urist, S. Ariyan, J. J. Sussman, et al.
Effect of Multiple-Nodal Basin Drainage on Cutaneous Melanoma
Arch Surg, July 1, 2008; 143(7): 632 - 638.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
M. Matter, M. Nicod Lalonde, M. Allaoua, A. Boubaker, D. Lienard, O. Gugerli, J.-P. Cerottini, H. Bouzourene, A. Bischof Delaloye, and F. Lejeune
The Role of Interval Nodes in Sentinel Lymph Node Mapping and Dissection for Melanoma Patients
J. Nucl. Med., October 1, 2007; 48(10): 1607 - 1613.
[Abstract] [Full Text] [PDF]

Home page
 Arch SurgHome page
K. M. McMasters, C. Chao, S. L. Wong, W. R. Wrightson, M. I. Ross, D. S. Reintgen, R. D. Noyes, P. B. Cerrito, M. J. Edwards, and for the Sunbelt Melanoma Trial Group
Interval Sentinel Lymph Nodes in Melanoma
Arch Surg, May 1, 2002; 137(5): 543 - 549.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1998 by the Society of Surgical Oncology.